Added Value for Tandem Mass Spectrometry Shotgun Proteomics Data Validation through Isoelectric Focusing of Peptides

2005 ◽  
Vol 4 (6) ◽  
pp. 2273-2282 ◽  
Author(s):  
Manfred Heller ◽  
Mingliang Ye ◽  
Philippe E. Michel ◽  
Patrick Morier ◽  
Daniel Stalder ◽  
...  

2015 ◽  
Vol 53 (6) ◽  
pp. 1927-1930 ◽  
Author(s):  
Hein Trip ◽  
Katrin Mende ◽  
Joanna A. Majchrzykiewicz-Koehorst ◽  
Norbert J. A. Sedee ◽  
Albert G. Hulst ◽  
...  

Shotgun proteomics using liquid chromatography-tandem mass spectrometry (LC-MS/MS) was applied to detect β-lactamases in clinicalAcinetobacter baumanniiisolates. The correlation of the detection of β-lactamase proteins (rather than PCR detection of the corresponding genes) with the resistance phenotypes demonstrated an added value for LC-MS/MS in antimicrobial susceptibility testing.



PROTEOMICS ◽  
2011 ◽  
Vol 11 (11) ◽  
pp. 2308-2319 ◽  
Author(s):  
S. O. Siu ◽  
Maggie P. Y. Lam ◽  
Edward Lau ◽  
Ricky P. W. Kong ◽  
Simon M. Y. Lee ◽  
...  


2020 ◽  
Vol 92 (24) ◽  
pp. 15890-15898
Author(s):  
Tian Xu ◽  
Xiaojing Shen ◽  
Zhichang Yang ◽  
Daoyang Chen ◽  
Rachele A. Lubeckyj ◽  
...  


2016 ◽  
Vol 54 (4) ◽  
pp. 653-663 ◽  
Author(s):  
Marianne Ibrahim ◽  
Rabah Gahoual ◽  
Ludovic Enkler ◽  
Hubert Dominique Becker ◽  
Johana Chicher ◽  
...  


2008 ◽  
Vol 54 (12) ◽  
pp. 2036-2041 ◽  
Author(s):  
François Boemer ◽  
Olivier Ketelslegers ◽  
Jean-Marc Minon ◽  
Vincent Bours ◽  
Roland Schoos

Abstract Background: Neonatal screening programs for sickle cell disease are now widespread in North American and European countries. Most programs apply isoelectric focusing or HPLC to detect hemoglobin variants. Because tandem mass spectrometry (MS/MS) is being used for screening of inherited metabolic disorders and allows protein identification, it was worth testing for hemoglobinopathy screening. Methods: We minimized sample preparation and analysis times by avoiding prior purification, derivatization, or separation. We developed a tryptic digestion methodology to screen for the main clinically important variants (Hb S, Hb C, and Hb E) and β-thalassemia. To ensure proper discrimination between homozygote and heterozygote variants, we selected 4 transitions with good signal intensities for each specific peptide and calculated variant/Hb A ratios for each. Method validation included intra- and interseries variability, carryover, and limit of detection. We also performed a comparative study with isoelectric focusing results on 2082 specimens. Results: Intraassay imprecision values (CVs) varied between 2.5% and 30.7%. Interassay CVs were between 6.3% and 23.6%. Carryover was <0.03%, and the limit of detection was fixed at 1% of Hb S. According to the MS/MS settings (detection of Hb S, Hb C, Hb E, and β-globin production defects), the comparative study did not yield any discrepant results between the 2 techniques. Conclusions: MS/MS is a reliable method for hemoglobinopathy neonatal screening.





2008 ◽  
Vol 5 (11) ◽  
pp. 959-964 ◽  
Author(s):  
Danielle L Swaney ◽  
Graeme C McAlister ◽  
Joshua J Coon


Sign in / Sign up

Export Citation Format

Share Document